AstraZeneca has maintained that while the vaccine may, in “very rare” cases, cause TTS, the casual mechanism for this effect remains unknown. Read this story
AstraZeneca has maintained that while the vaccine may, in “very rare” cases, cause TTS, the casual mechanism for this effect remains unknown. Read this story
More from Pharmaceutical Technology | Drug Development Vaccine AstraZeneca Serum Institute Of India